Stock Screener App

無料 -

インストール

6.28

0.32% -0.02

after-market

アフターアワーズ： 6.28

Neuraxis Inc (NRXS)

概要ニュース株価時系列ディスカッション予測

Neuraxis Inc (NRXS) 最新ニュース

NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up - NewsBreak: Local News & Alerts

NeurAxis revenues up 116% to USD 1.9M in Q2 2026 - Medical Buyer

NeurAxis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

NeurAxis (NRXS) Q2 2026 Earnings Call Transcript - The Globe and Mail

Could NeurAxis (NASDAQ:NRXS) Reshape Nasdaq Composite Focus? - Kalkine Media

Transcript : NeurAxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com

NeurAxis (NASDAQ:NRXS): What Could Today’s Update Reveal About Pediatric Therapy Adoption And Reimbursement? - Kalkine Media

NRXS: Q2 revenue up 116% YoY, gross margin at 85.9%, with payer coverage and VA expansion driving growth - TradingView

Earnings call transcript: NeurAxis falls on Q2 2026 EPS miss despite 116% revenue growth - Investing.com

NeurAxis reports 116% revenue growth in second quarter 2026 - Investing.com

NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth - The Manila Times

NRXS: Q2 2026 revenue surged 116% year-over-year, with gross margin up to 85.9% and strong cash position - TradingView

NeurAxis (NYSE American: NRXS) doubles sales yet warns on going concern - Stock Titan

Earnings To Watch: Neuraxis Inc (NRXS) Q2 2026 -- GF Value Sees 55% Downside - Yahoo Finance

NeurAxis, Inc. (NRXS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

NeurAxis宣佈爲IB-Stim PENFS療法增加美國中大西洋地區的覆蓋範圍，將服務擴展至超過500,000人 - Moomoo

Neuraxis Expands Payer Coverage for Percutaneous Electrical Nerve Field Stimulation and Ib-Stim Treatment - marketscreener.com

NeurAxis expands insurance coverage for its IB-Stim neuromodulation device, adding 500,000 covered lives. - Pluang

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

NRXS|Neuraxis Inc|Price:6.735|Chg%:+0.485 - TradingKey

Neuraxis Inc (NRXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 - The Manila Times

NeurAxis, Inc. to Report Second Quarter 2026 Financial Results on August 11 and Host Conference Call - Quiver Quantitative

Neuraxis Inc (NRXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Neuraxis Inc (NRXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Neuraxis Inc (NRXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Neuraxis Inc (NRXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

NRXS|Neuraxis Inc|Price:6.800| - TradingKey

Neuraxis Inc (NRXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

TradingKey - TradingKey

Neuraxis, Inc. Revenue Breakdown – AMEX:NRXS - TradingView

Form S-3 Neuraxis Inc For: 24 July By Investing.com - Investing.com South Africa

Neuraxis Inc. (NRXS) Q1 2026 Earnings: EPS Beat Despite Negative Bottom Line, Stock SlidesEarnings Season Preview - DonanımHaber

Neuraxis, Inc. Files Form 8-K with SEC: Company Details, Address, and Stock Listing on NYSE American - Minichart

NeurAxis Declares Q2 Stock Dividend on Series B - TipRanks

Neuraxis declares stock dividend for Series B preferred, ~80,463 common shares to be issued - TradingView

NRXSNeuraxis Inc Latest SEC Filings - Finviz

Neuraxis Inc. (NRXS) Holds Steady Near Resistance Amid Low Volatility SessionPost-Earnings Moves - dars.gov.et

Neuraxis Inc. (NRXS) Hovers Near Key Support Level After Modest DeclineMACD Signal Stocks - dars.gov.et

NeurAxis, Inc.(NYSEAM: NRXS) added to Russell Microcap Growth Benchmark Index - marketscreener.com

NeurAxis, Inc.(NYSEAM: NRXS) added to Russell 3000E Growth Benchmark - marketscreener.com

NeurAxis, Inc.(NYSEAM: NRXS) added to Russell Microcap Index - marketscreener.com

NeurAxis, Inc.(NYSEAM: NRXS) added to Russell 3000E Index - marketscreener.com

Price to sales forward of Neuraxis, Inc. – AMEX:NRXS - TradingView

Price to sales forward of Neuraxis, Inc. – BOATS:NRXS - TradingView

Enterprise value to EBIT forward of Neuraxis, Inc. – AMEX:NRXS - TradingView

Enterprise value to EBIT forward of Neuraxis, Inc. – BOATS:NRXS - TradingView

Price to book forward of Neuraxis, Inc. – AMEX:NRXS - TradingView

Enterprise value to revenue forward of Neuraxis, Inc. – AMEX:NRXS - TradingView

Price to earnings forward of Neuraxis, Inc. – BOATS:NRXS - TradingView

Enterprise value to EBITDA forward of Neuraxis, Inc. – BOATS:NRXS - TradingView

NRXS Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Investor SentimentProfit Inflection Point - dars.gov.et

NeurAxis, Inc. Actuals & Estimates (AMEX:NRXS) - TradingView

NRXS Forecast — Price Target — Prediction for 2027 - TradingView

Neuraxis Inc (NRXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

NRXS Q1 2026 Earnings: EPS Surprises to the Upside, Stock Climbs 6.56%Earnings Surprise Stocks - dars.gov.et

Neuraxis Inc. (NRXS) Surges 6.56% as Momentum Builds Above Key SupportGap and Reverse - dars.gov.et

Neuraxis Inc (NRXS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Neuraxis Inc (NRXS) Institutional Confidence - TradingKey

Neuraxis Inc. (NRXS) Holds Steady Near Support Level as Market Awaits CatalystBreadth Thrust - dars.gov.et

MRNA

$64.46

1.80%

ROIV

$36.24

0.11%

RPRX

$59.45

1.45%

INSM

$128.32

3.70%

ALNY

$224.60

1.77%

ONC

$362.51

4.33%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く